|
Affinity Biosciences
cytochrome c cyt c Cytochrome C Cyt C, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/c+c+cyt+cytochrome/pmc12914111-39-0-70 Average 86 stars, based on 1 article reviews
cytochrome c cyt c - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Galectin Therapeutics
apo cyt c Apo Cyt C, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/pm42046264-195-86-18 Average 86 stars, based on 1 article reviews
apo cyt c - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Oroboros Instruments
cyt c ![]() Cyt C, supplied by Oroboros Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/c+cyt/pmc13019506-287-18-13 Average 86 stars, based on 1 article reviews
cyt c - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Thermo Fisher
cytochrome c cyt c ![]() Cytochrome C Cyt C, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/Cytochrome+C/pm41894877-91-4-18 Average 96 stars, based on 1 article reviews
cytochrome c cyt c - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Wanleibio
cyt c ![]() Cyt C, supplied by Wanleibio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/anti+c+cyt/pm41833110-69-48-51 Average 86 stars, based on 1 article reviews
cyt c - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Thermo Fisher
antibody against cytochrome c cyt c ![]() Antibody Against Cytochrome C Cyt C, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/Cytochrome+C/pm41812974-118-11-22 Average 96 stars, based on 1 article reviews
antibody against cytochrome c cyt c - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Nanjing Jiancheng Bioengineering Research Institute Co Ltd
cyt c ![]() Cyt C, supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/c+cyt/pmc12891905-90-24-33 Average 86 stars, based on 1 article reviews
cyt c - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
cyt c ![]() Cyt C, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/Cytochrome+c+Antibody/pm41690088-71-31-41 Average 96 stars, based on 1 article reviews
cyt c - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Proteintech
cyt c ![]() Cyt C, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cyt+c/Cytochrome+c+Antibody/pmc13045231-226-122-125 Average 96 stars, based on 1 article reviews
cyt c - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
Journal: iScience
Article Title: Accumulated mtDNA mutations are linked to specific impairments in NADH-linked respiration
doi: 10.1016/j.isci.2026.115184
Figure Lengend Snippet: PolG Mut mitochondria possess selective impairments to NAD-linked Respiration (A) Schematic depiction of the substrates and inhibitors added during the OxPhos kinetics assay. Mitochondrial oxygen consumption ( J O 2 ) across OxPhos kinetics assay in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung tissue. Ratio of maximal complex I (CI) versus CII-supported mitochondrial J O 2 (I). N = 4–6 per group. Data are presented as mean ± SEM and analyzed using multiple unpaired t tests ( B–5H) or unpaired t test ( I), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM; pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM), and antimycin A (Ant A; 0.5 μM). Graphics were generated using BioRender.
Article Snippet: Following freeze fracture, 20μg of mitochondria were added to Respiration Buffer in the
Techniques: Isolation, Generated
Journal: iScience
Article Title: Accumulated mtDNA mutations are linked to specific impairments in NADH-linked respiration
doi: 10.1016/j.isci.2026.115184
Figure Lengend Snippet: Respiratory capacity within the electron transport system remains intact in PolG Mut mice (A–H) Schematic representing the maximal respiratory capacity protocol. Real-time oxygen consumption ( J O 2 ) in mitochondria isolated from (B) BAT, (C) brain, (D) colon, (E) heart, (F) kidney, (G) Liver, (H) and lung following serial titration of the mitochondrial uncoupling agent, carbonyl cyanide- p -trifluoromethoxyphenylhydrazone (FCCP, FC; 0.25 μM). (I) Maximal mitochondrial respiration achieved during FCCP titration. N = 5–6 per group, Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 depict significant post hoc LSD by two-way ANOVA; main effect PolG ( B–4H) or unpaired t test ( I). Substrates utilized are indicated as follows: pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), succinate (Succ; 5 mM) cytochrome c (Cyt C, 10 μM). Graphics were generated using BioRender.
Article Snippet: Following freeze fracture, 20μg of mitochondria were added to Respiration Buffer in the
Techniques: Isolation, Titration, Generated
Journal: iScience
Article Title: Accumulated mtDNA mutations are linked to specific impairments in NADH-linked respiration
doi: 10.1016/j.isci.2026.115184
Figure Lengend Snippet: Mitochondrial respiratory phenotypes are maintained in permeabilized tissue (A) Tissue slices were permeabilized in saponin before assessment of oxygen consumption ( J O 2 ). (B) Intact colon, (C) heart, and (D) liver J O 2 under multiple substrate conditions. (E) Ratio of complex I (CI) versus CII-supported respiration. (F) Dose-response to FCCP titration and (G) maximal respiratory capacity in intact bone marrow-derived mononuclear cells (BMMCs). (H) Mitochondrial J O 2 during OxPhos kinetics technique in permeabilized BMMCs. (I) Ratio of CI versus CII-supported respiration in permeabilized BMMCs. N = 5 per group. Data are presented as mean ± SEM, p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001,∗∗∗∗ p < 0.00001 depict significant multiple unpaired t tests ( A–6C and 6G), and unpaired t test ( D–6F and 6H). Substrates utilized are indicated as follows: creatine kinase (CK; 20 U/mL), ATP (5 mM), phospho-creatine (PCr; 1 mM), cytochrome c (Cyt C; 10 μM), pyruvate (Pyr; 5 mM), malate (Mal; 1 mM), octanoyl-carnitine (Oct; 0.2 mM), glutamate (Glut; 5 mM), rotenone (Rot; 0.5 μM), succinate (Succ; 5 mM) oligomycin (Oligo; 0.02 μM), malonate (Malo; 20 mM), calcium chloride (CaCl 2 ; 0.6 mM) glycerol-3-phosphate (G3P; 10 mM) antimycin A (Ant A; 0.5 μM), and carbonyl cyanide- p -trifluoromethoxyphenylhydrazone (FCCP, FC; 0.25 μM). Graphics were generated using BioRender.
Article Snippet: Following freeze fracture, 20μg of mitochondria were added to Respiration Buffer in the
Techniques: Titration, Derivative Assay, Generated
Journal: Redox Biology
Article Title: Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis
doi: 10.1016/j.redox.2026.104016
Figure Lengend Snippet: ACO2 overexpression protected against LIRI in mice. (A) Schematic of AAV9-mediated ACO2-OE in I/R mice. (B–C) ACO2 expression levels assessed by RT-qPCR and western blot. (D) Blood gas parameters (PaO 2 and PaCO 2 ) following I/R injury. (E) Representative H&E-stained lung sections (scale bars = 20/50 μm, Black arrow: Alveolar expansion; Red arrow: Hemorrhage; Green arrow: Alveolar septum thickening and inflammatory cell infiltration). (F–G) Quantitative assessment of lung injury via histopathological scoring and wet/dry weight ratio. (H) Total cells count and protein concentration in BALF. (I) The mRNA expression of pro-inflammatory cytokines ( IL-6 , IL-1β , and TNF-α ). (J–K) Oxidative stress markers: T-AOC and MDA. (L) Apoptosis-related gene expression ( caspase 9 , Bcl-2, BAX , and Cyt-c ). (M) Mitochondrial respiratory function measured by OCR. (N) Serum Cyt-c release. (O) TUNEL staining for apoptosis detection (scale bar = 20 μm). Data are presented as the mean ± SD; n = 6; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.
Article Snippet: Contents of MDA (Cat. No: A003-1-2 ), MPO (Cat. No: A044-1-1), GSH (Cat. No: A006-2-1), T-AOC (Cat. No: A015-2-1), SOD (Cat. No: A001-3-2), and
Techniques: Over Expression, Expressing, Quantitative RT-PCR, Western Blot, Staining, Protein Concentration, Gene Expression, TUNEL Assay
Journal: Redox Biology
Article Title: Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis
doi: 10.1016/j.redox.2026.104016
Figure Lengend Snippet: ACO2-KO exacerbated mitochondrial damage and apoptosis in HUVECs. (A–B) Validation of ACO2-KO efficiency by RT-qPCR and western blot. (C) Representative TEM images showing mitochondrial ultrastructural changes. The red arrows indicate the disappearance of mitochondrial cristae. (D) Cellular ATP contents measured by enzymatic assay. (E) The mtDNA copy number assessed via quantification of mitochondrial genes (ND-1, COX I, and COX IV). (F) Mitochondrial superoxide production detected by MitoSOX Red staining (scale bar = 20 μm). (G) Mitochondrial respiratory function measured by OCR. (H–I) Metabolomic analysis of TCA cycle intermediates: itaconate and isocitrate. (J) The mRNA expression of apoptosis-related genes ( Bcl-2, BAX, and Caspase-9 ). (K) Cyt-c release from mitochondria. (L) Apoptosis evaluation by TUNEL staining (scale bar = 20 μm). Data are presented as the mean ± SD; n = 3; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, and ∗∗∗∗ P < 0.0001.
Article Snippet: Contents of MDA (Cat. No: A003-1-2 ), MPO (Cat. No: A044-1-1), GSH (Cat. No: A006-2-1), T-AOC (Cat. No: A015-2-1), SOD (Cat. No: A001-3-2), and
Techniques: Biomarker Discovery, Quantitative RT-PCR, Western Blot, Enzymatic Assay, Staining, Metabolomic, Expressing, TUNEL Assay
Journal: Redox Biology
Article Title: Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis
doi: 10.1016/j.redox.2026.104016
Figure Lengend Snippet: 4-OI rescued mitochondrial dysfunction after ACO2-KO in HUVECs. (A) Mitochondrial mass assessed by MitoTracker staining (scale bar = 20 μm). (B) Mitochondrial respiratory function measured by OCR. (C) Mitochondrial membrane potential evaluated using JC-1 staining (scale bar = 20 μm). (D) Activities of mitochondrial ETC complexes. (E) Protein contents of ETC complex subunits. (F–G) Metabolic ratios of NAD + /NADH and ATP/ADP. (H–I) The mRNA expression of apoptosis-related genes ( caspase-9 and BAX ). (J) Apoptosis-related protein contents (cleaved caspase-3, Bcl-2, and BAX) analyzed by western blot with semi-quantitative analysis. (K) Cyt-c release from mitochondria. (L) Apoptosis evaluation by TUNEL staining (scale bar = 20 μm). Data are presented as the mean ± SD; n = 3; ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001.
Article Snippet: Contents of MDA (Cat. No: A003-1-2 ), MPO (Cat. No: A044-1-1), GSH (Cat. No: A006-2-1), T-AOC (Cat. No: A015-2-1), SOD (Cat. No: A001-3-2), and
Techniques: Staining, Membrane, Expressing, Western Blot, TUNEL Assay
Journal: Advanced Science
Article Title: Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage‐Induced Mitochondrial Apoptosis and Parthanatos‐Like Cell Death
doi: 10.1002/advs.202511406
Figure Lengend Snippet: HIF disrupts mitochondrial homeostasis and decreases ATP production. (A–C) Representative immunofluorescence images show the subcellular localization and nuclear translocation of AIF, MIF, and Cytochrome c (Cyt c) in HCT15 and HCT116 cells following 24 h HIF treatment. (D, E) Quantification of intracellular reactive oxygen species (ROS) levels in HCT15 and HCT116 cells, respectively. (F, G) Quantification of mitochondrial ROS intensity using mitoSOX staining in HCT15 and HCT116 cells, respectively. (H, I) Oxygen consumption rate (OCR) fluorescence intensity in HCT15 and HCT116 cells, reflecting changes in mitochondrial respiration. (J, K) Relative intracellular ATP levels in HCT15 and HCT116 cells following HIF treatment. (L) Flow cytometric analysis of mitochondrial membrane potential (Δψm) in HCT15 and HCT116 cells after HIF treatment, assessed using JC‐1 staining. The red‐to‐green fluorescence intensity ratio was used to quantify alterations in membrane potential (right panels). ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Article Snippet: The membranes were then blocked with a 5% non‐fat milk TBST (TBS containing 0.1% Tween‐20) for 1 h at room temperature and incubated at 4°C for overnight with primary antibodies against the following proteins: cleaved Caspase 3 (25128‐1‐AP, Proteintech), cleaved Caspase 8 (9496, CST), PARP (9542, CST), cleaved PARP (9541, CST), P21 (2947, CST), P53 (2527, CST), Cyclin A2 (91500, CST), Cyclin D1 (2978, CST), CDK1 (bs‐1341R, Bioss), CDK2 (bs‐10726R, Bioss), CDK7 (bs‐0569R, Bioss), AKT (4691, CST), p‐AKT (4060, CST), ERK (9102, CST), p‐ERK (9101, CST), MEK (9126, CST), p‐MEK (9154, CST), ATR (13934, CST), p‐ATR (2853, CST), Chk1 (2360, CST), p‐Chk1 (2348, CST), RAD51 (14961‐1‐AP, Proteintech), ATM (27156‐1‐AP, Proteintech), p‐ATM (5883, CST), γ‐H2AX (9718, CST), AIF (5318, CST), MIF (75038, CST),
Techniques: Immunofluorescence, Translocation Assay, Staining, Fluorescence, Membrane
Journal: Advanced Science
Article Title: Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage‐Induced Mitochondrial Apoptosis and Parthanatos‐Like Cell Death
doi: 10.1002/advs.202511406
Figure Lengend Snippet: HIF suppresses CRC tumor growth in vivo. (A) Tumor growth in mouse models bearing HCT116 cells treated with HIF, 5‐FU, or the combination. (B) Final tumor weights were measured at the end of treatment across treatment groups. (C) Representative images of excised tumors from each group. (D) Body weight monitoring throughout the treatment period. (E, F) H&E and IHC analysis of tumor tissues for Ki67, Cyt c, c‐Caspase‐3, and c‐PARP, with corresponding quantification. (G) H&E and IHC staining of kidney and liver tissues to evaluate potential organ toxicity. (H–J) Immunofluorescence analysis of γ‐H2AX, AIF, and MIF localization in tumor tissues. Nuclei are stained with DAPI (blue), and target proteins appear in green. (K) Schematic representation illustrating the proposed mechanism by which HIF‐induced DNA damage leads to mitochondrial apoptosis and parthanatos‐mediated colorectal tumor cell death. ** p < 0.01, **** p < 0.0001.
Article Snippet: The membranes were then blocked with a 5% non‐fat milk TBST (TBS containing 0.1% Tween‐20) for 1 h at room temperature and incubated at 4°C for overnight with primary antibodies against the following proteins: cleaved Caspase 3 (25128‐1‐AP, Proteintech), cleaved Caspase 8 (9496, CST), PARP (9542, CST), cleaved PARP (9541, CST), P21 (2947, CST), P53 (2527, CST), Cyclin A2 (91500, CST), Cyclin D1 (2978, CST), CDK1 (bs‐1341R, Bioss), CDK2 (bs‐10726R, Bioss), CDK7 (bs‐0569R, Bioss), AKT (4691, CST), p‐AKT (4060, CST), ERK (9102, CST), p‐ERK (9101, CST), MEK (9126, CST), p‐MEK (9154, CST), ATR (13934, CST), p‐ATR (2853, CST), Chk1 (2360, CST), p‐Chk1 (2348, CST), RAD51 (14961‐1‐AP, Proteintech), ATM (27156‐1‐AP, Proteintech), p‐ATM (5883, CST), γ‐H2AX (9718, CST), AIF (5318, CST), MIF (75038, CST),
Techniques: In Vivo, Immunohistochemistry, Immunofluorescence, Staining